1. ALLA AKTIER
  2. NYHETER
  3. AROCELL

AroCell

Nyheter AroCell Nyheter alla bolag

The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024

MAR

The Nomination Committee proposes the election of Max Pihlqvist as the Chairman of the Board, and the election of Fredrik Lindgren as a new board member for AroCells Board of Directors at the 2024 Annual General Meeting.

Fredrik Lindgren has over 25 years of experience in the Life Science sector, where he has served as a CEO or board member in more than 10 different companies. He served as the Managing Director at Larodan AB until 2023, and previously, he held the role as CEO at Karo Pharma AB and Biolin Scientific AB. Fredrik holds a law degree from Lund University and an eMBA from Stockholm School of Business.

The nomination committee´s proposal for the board at the AGM is the re-election of Eva Nordström, Agneta Tufvesson Alm, Clas Runnberg, and Max Pihlqvist, and the new election of Fredrik Lindgren.

The Nomination Committee proposes the new election of Max Pihlqvist as the Chairman of the Board.

AroCells Nomination Committee consists of:
Christian Lindgren (Chairman)
Clas Runnberg
Jon Eiken

Contacts

Anders Hultman, CEO
Phone: +46 (0) 8 799 67 50
E-mail: anders.hultman@arocell.com

About AroCell

AroCell AB (publ) is a Swedish company that develops and markets blood and urine sample tests. The corporation specializes in oncology and bacteriology. The company has a broad product portfolio, used in healthcare, and established in various markets. In oncology, AroCell uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as company's Certified Adviser. For more information; www.arocell.com

This information is information that AroCell is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-03-12 12:30 CET.

Attachments

The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024

Datum 2024-03-12, kl 12:30
Källa MFN
Bifogade filer
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!